{"id":6153,"date":"2025-08-25T07:52:05","date_gmt":"2025-08-25T04:52:05","guid":{"rendered":"https:\/\/prostatefocaltherapies.com\/prostat-fuzyon-biyopsisi\/"},"modified":"2025-09-26T06:13:39","modified_gmt":"2025-09-26T03:13:39","slug":"prostat-fuzyon-biyopsisi","status":"publish","type":"page","link":"https:\/\/prostatefocaltherapies.com\/tr\/prostat-fuzyon-biyopsisi\/","title":{"rendered":"Prostat F\u00fczyon Biyopsisi"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Prostat F\u00fczyon Biyopsisi<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

MR\/TRUS F\u00fczyon Biyopsi - Nas\u0131l Yap\u0131l\u0131r?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

TRUS biyopsisi prostat kanserli hastalarda standart yakla\u015f\u0131m olarak kabul edilir. Ancak prostat kanserinin %25-39’unun izoekoik g\u00f6r\u00fcnmesi, TRUS kullan\u0131larak hedeflenen lezyonlardan \u00f6rnek al\u0131nmas\u0131n\u0131n her zaman m\u00fcmk\u00fcn olmamas\u0131 ve biyopsilerin radikal prostatektomi \u00f6rnekleri ile uyumsuzlu\u011fu, TRUS biyopsisinin do\u011frulu\u011funu art\u0131rmak i\u00e7in ek y\u00f6ntemlere ihtiya\u00e7 oldu\u011funu d\u00fc\u015f\u00fcnd\u00fcrmektedir. Yap\u0131lan \u00e7al\u0131\u015fmalar TRUS biyopsisinin prostat kanserinin tan\u0131s\u0131, t\u00fcm\u00f6r\u00fcn yeri, derecesi veya yayg\u0131nl\u0131\u011f\u0131 hakk\u0131nda yeterli bilgi vermedi\u011fini g\u00f6stermektedir. TRUS biyopsisi ile \u00f6zellikle santral lobda ve prostat apeksinde olan kanserlerin tan\u0131s\u0131n\u0131n m\u00fcmk\u00fcn olmad\u0131\u011f\u0131 anla\u015f\u0131ld\u0131. Konvansiyonel TRUS biyopsisi bazen biyopsilerin tekrarlanmas\u0131n\u0131 gerektirir. Ba\u015flang\u0131\u00e7ta, bu t\u00fcr tekrarlanan biyopsi prosed\u00fcrleri durumunda daha doymu\u015f biyopsiler yap\u0131ld\u0131. Ancak son y\u0131llarda daha hedefe y\u00f6nelik biyopsiler yayg\u0131nla\u015ft\u0131. G\u00fcn\u00fcm\u00fczde TRUS biyopsi sonu\u00e7lar\u0131 negatif olan ancak \u015f\u00fcpheleri devam eden hastalar i\u00e7in Mp-MR sonu\u00e7lar\u0131na g\u00f6re hedefe y\u00f6nelik biyopsi yap\u0131lmaktad\u0131r. Bu y\u00f6ntem sat\u00fcrasyon biyopsisine ciddi bir alternatif haline geldi. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Hedefe Y\u00f6nelik Biyopsi Teknikleri\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

MRG g\u00f6r\u00fcnt\u00fcleri ve US g\u00f6r\u00fcnt\u00fclerinin kombinasyonuna g\u00f6re 3 farkl\u0131 f\u00fczyon biyopsisi tan\u0131mland\u0131;<\/p>

  • <\/i> Bili\u015fsel f\u00fczyon biyopsisi<\/li>
  • <\/i> MR (In-Bore) e\u015fli\u011finde f\u00fczyon biyopsisi<\/li>
  • <\/i> MR-TRUS f\u00fczyon biyopsisi<\/li><\/ul>

    \"\"<\/p>

    <\/p>

    Kognitif f\u00fczyon biyopsisi;<\/strong> bu, Mp-MRI arac\u0131l\u0131\u011f\u0131yla \u015f\u00fcpheli alanlar\u0131n belirlenmesi, bu alan\u0131n TRUS ile yakla\u015f\u0131k olarak tan\u0131mlanmas\u0131 ve ard\u0131ndan biyopsi i\u015fleminin ger\u00e7ekle\u015ftirilmesiyle yap\u0131l\u0131r. Kognitif f\u00fczyon biyopsisi, standart USG cihaz\u0131 d\u0131\u015f\u0131nda herhangi bir cihaz gerektirmez. Pratik ve ucuz bir y\u00f6ntemdir. Ancak MP-MRI, USG deneyimi ve 3 boyutlu bili\u015fsel yetenekler gerektirir. K\u00fc\u00e7\u00fck lezyonlarda, \u00f6n ve apikal lezyonlarda hedefleme zordur. <\/p>

    \"\"<\/p>

    Direkt MRG (In-Bore) e\u015fli\u011finde f\u00fczyon biyopsisi;<\/strong> MR cihaz\u0131ndayken \u015f\u00fcpheli lezyonlardan ger\u00e7ek zamanl\u0131 olarak biyopsi i\u00e7in \u00f6rnek alma uygulamas\u0131d\u0131r. Hedeflenen lezyonlarda biyopsi prosed\u00fcr\u00fc yakla\u015f\u0131k 60 ila 90 dakika s\u00fcrer. Bu nedenle In-Bore biyopsi ile ayn\u0131 seansta sistematik biyopsi yap\u0131lamaz. Ayr\u0131ca maliyetler, pozisyonun zorlu\u011fu, iki kez MR \u00e7ektirmek zorunda kalma zorunlulu\u011fu da di\u011fer dezavantajlar\u0131 olarak g\u00f6sterilebilir. <\/p>

    Mp-MRI\/TRUS f\u00fczyon biyopsisi;<\/strong> Mp-MR\/TRUS f\u00fczyon biyopsi tekni\u011finde MR g\u00f6r\u00fcnt\u00fcleri USG tabanl\u0131 \u00f6zel bir cihaza g\u00f6nderilir. Prostat \u00e7e\u015fitli yaz\u0131l\u0131mlar kullan\u0131larak segmente edilecek ve TRUS g\u00f6r\u00fcnt\u00fcleri kullan\u0131larak f\u00fczyon ger\u00e7ekle\u015ftirilecektir. MRI ve TRUS g\u00f6r\u00fcnt\u00fcleri \u00fcst \u00fcste bindirilir veya yan yana yerle\u015ftirilir ve ger\u00e7ek zamanl\u0131 olarak taran\u0131r ve biyopsi, ultrason rehberli\u011finde MRG’de i\u015faretlenen lezyon \u00fczerinde ger\u00e7ekle\u015ftirilir. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    Mp-MRI\/TRUS F\u00fczyon Biyopsisinin Bili\u015fsel F\u00fczyona G\u00f6re Avantajlar\u0131:\n\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    • <\/i> Lezyon boyutuna ba\u011fl\u0131 olarak daha do\u011fru \u00f6rnekleme<\/li>
    • <\/i> Numunenin nereden al\u0131nd\u0131\u011f\u0131n\u0131 net bir \u015fekilde g\u00f6rebilmek (cihaz buna izin veriyorsa)<\/li>
    • <\/i> Sistematik biyopside daha homojen \u00f6rnekleme<\/li><\/ul>

      Mp-MRI\/TRUS f\u00fczyon biyopsisinin In-bore biyopsiye g\u00f6re avantajlar\u0131;<\/strong><\/h3>
      • <\/i> Hedeften \u00f6rnek al\u0131nmas\u0131na ek olarak sistematik biyopsi yap\u0131lmas\u0131na olanak sa\u011flar,<\/li>
      • <\/i> Daha h\u0131zl\u0131 biyopsi (klinik ortamda daha pratik)<\/li>
      • <\/i> Daha y\u00fcksek d\u00fczeyde hasta konforu<\/li><\/ul>

        \u00d6\u011frenme e\u011frisinin uzunlu\u011fu ve biyopsi \u00f6ncesi segmentasyon i\u015flemlerinin \u00e7ok zaman almas\u0131n\u0131n yan\u0131 s\u0131ra birden fazla cihaz kullan\u0131m\u0131 ile ilgili sorunlar MR\/TRUS f\u00fczyon biyopsisinin dezavantajlar\u0131d\u0131r.<\/p>

        Prostat kanseri taramalar\u0131;<\/strong> PSA kan testi<\/strong> ve DRE’yi (dijital rektum muayenesi) i\u00e7erebilir. DRE veya PSA testleri anormal ise doktorlar transrektal ultrason ile TRUS biyopsisi yapabilirler. Biyopsi negatifse, hasta d\u00fczenli PSA testleri ile taranabilir. Ancak hastada DRE pozitifse veya s\u00fcrekli artan PSA ve negatif TRUS biyopsi sonu\u00e7lar\u0131 varsa f\u00fczyon rehberli\u011finde prostat biyopsisi ileri tarama ve tan\u0131 i\u00e7in bir se\u00e7enektir. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

        \n\t\t\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t
        \n\t\t\t\t\t\t
        \n\t\t\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t
        \n\t\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t

        F\u00fczyon Biyopsisi Kimlere Yap\u0131lmal\u0131d\u0131r?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t

        \"\"<\/p>

        Prostat biyopsi sonu\u00e7lar\u0131 negatif olmas\u0131na ra\u011fmen hastada prostat kanseri \u015f\u00fcphesi devam ediyorsa MR f\u00fczyon biyopsisi yap\u0131lmal\u0131d\u0131r. \u00c7\u00fcnk\u00fc yap\u0131lan ara\u015ft\u0131rmalara g\u00f6re biyopsi sonucu negatif \u00e7\u0131kan her d\u00f6rt ki\u015fiden biri \u00f6n\u00fcm\u00fczdeki 20 y\u0131l i\u00e7inde prostat kanserine yakalan\u0131yor. Bu ayn\u0131 zamanda parmakla rektum muayenesinde anormalli\u011fi olan veya PSA de\u011ferleri y\u00fcksek olan hastalar i\u00e7in de \u00f6nerilmektedir. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

        \n\t\t\t\t
        \n\t\t\t\t\t

        F\u00fczyon Biyopsi Nas\u0131l Yap\u0131l\u0131r?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t

        \"\"<\/p>

        Biyopsi \u00f6ncesi hastalara prostat\u0131n multi-parametrik MR’\u0131 yap\u0131lacakt\u0131r. MR’daki g\u00f6r\u00fcnt\u00fcler kanser a\u00e7\u0131s\u0131ndan \u015f\u00fcpheli alanlar\u0131n belirlenmesinde kullan\u0131lacak ve bu alanlar g\u00f6r\u00fcnt\u00fcler \u00fczerinde i\u015faretlenecek. Bu esnada hasta sakinle\u015ftirilecek ve hastan\u0131n rektumunun i\u00e7ine ultrason probu yerle\u015ftirilerek prostat\u0131n g\u00f6r\u00fcnt\u00fclenmesi sa\u011flanacakt\u0131r. Prostat\u0131n 3D multi-parametrik MRI g\u00f6r\u00fcnt\u00fcleri, rektum probundan al\u0131nan ultrason g\u00f6r\u00fcnt\u00fclerinin \u00fczerine bindirilecektir. Bu nedenle f\u00fczyon biyopsi olarak adland\u0131r\u0131l\u0131r. Daha sonra biyopsi i\u011fnesi i\u015faretlenen b\u00f6lgeye g\u00f6t\u00fcr\u00fclecek ve \u00f6rnek alma i\u015flemi tamamlanacakt\u0131r. <\/p>

        Mp-MR\/TRUS f\u00fczyon biyopsisi ile \u015f\u00fcpheli lezyondan al\u0131nacak \u00f6rnek say\u0131s\u0131<\/strong><\/p>

        Hem EAU hem de AUA prostat kanseri k\u0131lavuzlar\u0131, Mp-MRG ile belirlenen lezyonlardan al\u0131nmas\u0131 gereken \u00f6rnek say\u0131s\u0131 konusunda kesin bir \u00f6neri sunmamaktad\u0131r. Yap\u0131lan \u00e7al\u0131\u015fmalar bu say\u0131n\u0131n de\u011fi\u015febilece\u011fini g\u00f6stermektedir ancak \u015f\u00fcpheli lezyondan en az iki \u00f6rnek al\u0131nmas\u0131 \u00f6nemlidir. <\/p>

        \"\"<\/p><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

        \n\t\t\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t
        \n\t\t\t\t\t\t
        \n\t\t\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t
        \n\t\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t

        F\u00fczyon Biyopsinin Konvansiyonel Prostat Biyopsisine G\u00f6re Avantajlar\u0131 Nelerdir?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        • <\/i> F\u00fczyon y\u00f6ntemi, prostat\u0131n \u00fc\u00e7 boyutlu haritas\u0131n\u0131 olu\u015fturur ve biyopsi i\u011fnesini kanserli oldu\u011fundan \u015f\u00fcphelenilen b\u00f6lgelere y\u00f6nlendirir.<\/li>
        • <\/i> Konvansiyonel biyopsi tedavisi alan hastalarda agresif yay\u0131lan prostat kanserleri g\u00f6zden ka\u00e7abilir ancak f\u00fczyon biyopsi ile yakalanma olas\u0131l\u0131\u011f\u0131 daha y\u00fcksektir.<\/li>
        • <\/i> Konvansiyonel biyopside al\u0131nan doku say\u0131s\u0131na ba\u011fl\u0131 olarak koruyucu \u00f6nlemlere ra\u011fmen enfeksiyon ve septik komplikasyon riski y\u00fcksektir. Bu f\u00fczyon biyopsisi sadece hedefe yap\u0131l\u0131r, bu nedenle numune say\u0131s\u0131 daha d\u00fc\u015f\u00fck olacak ve bu da enfektif komplikasyon riskini azaltacakt\u0131r. <\/li><\/ul>

          \u00d6zetle faydal\u0131d\u0131r \u00e7\u00fcnk\u00fc;<\/strong><\/p>

          • <\/i> Ek inceleme gerektiren \u015f\u00fcpheli alanlar\u0131 do\u011fru bir \u015fekilde belirleyecektir<\/li>
          • <\/i> \u0130htiya\u00e7 duyulan doku \u00f6rneklerinin say\u0131s\u0131n\u0131 azaltabilir<\/li>
          • <\/i> Daha az a\u011fr\u0131l\u0131 ve daha d\u00fc\u015f\u00fck enfeksiyon ve kanama riski<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t

            Biyopsi \u00d6ncesi Hangi Haz\u0131rl\u0131klar Gereklidir?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            \"\"<\/p>

            \u0130\u015flemden \u00f6nce enfeksiyon riskini azaltmak i\u00e7in birka\u00e7 g\u00fcn antibiyotik verilecektir. Hasta aspirin gibi kan suland\u0131r\u0131c\u0131 ila\u00e7lar kullanmamal\u0131d\u0131r. Hasta bu t\u00fcr bir ila\u00e7 kullan\u0131yorsa, hastan\u0131n doktor kontrol\u00fcnde bir hafta boyunca o ilac\u0131 almay\u0131 b\u0131rakmas\u0131 \u00f6nemlidir. Hastan\u0131n i\u015flemden \u00f6nceki son alt\u0131 saat i\u00e7inde yemek yemeyi b\u0131rakmas\u0131 \u00f6nemlidir. \u0130\u015flem s\u0131ras\u0131nda rektumun bo\u015f olmas\u0131 gerekti\u011finden, kab\u0131zl\u0131k \u00e7eken hastalar\u0131n m\u00fcshil kullanmas\u0131 gerekebilir. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

            \n\t\t\t\t
            \n\t\t\t\t\t

            \u0130\u015flem ne kadar s\u00fcrer?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            \u0130\u015flem 15 ila 25 dakika s\u00fcrer.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

            \n\t\t\t\t
            \n\t\t\t\t\t

            \u0130\u015flem a\u011fr\u0131l\u0131 olur mu?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            Anestezik ila\u00e7lar sayesinde hastalar genellikle f\u00fczyon biyopsisi s\u0131ras\u0131nda herhangi bir a\u011fr\u0131 hissetmezler.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

            \n\t\t\t\t
            \n\t\t\t\t\t

            Biyopsi Sonras\u0131 \u0130\u015flem Nedir?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            Biyopsiden sonraki bir hafta boyunca idrarda, d\u0131\u015fk\u0131da ve menide \u00fc\u00e7 ay boyunca kan olabilir. Bu endi\u015felenmek i\u00e7in bir neden de\u011fildir ve kanama kendili\u011finden duracakt\u0131r. En son EAU k\u0131lavuzu, biyopsi \u00f6ncesi oral veya intraven\u00f6z antibiyotik kullan\u0131m\u0131n\u0131 \u00f6nermekte ve ilk se\u00e7enek olarak kinolon antibiyotikleri \u00f6nermektedir. Ancak lokal antibiyotiklerin direnci de dikkate al\u0131nmal\u0131d\u0131r. Bu s\u00fcre zarf\u0131nda ate\u015fle kar\u015f\u0131la\u015f\u0131l\u0131rsa (nadiren g\u00f6r\u00fcl\u00fcr) doktora ba\u015fvurulmal\u0131d\u0131r. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

            \n\t\t\t\t
            \n\t\t\t\t\t

            Biyopsi Sonras\u0131 Hasta Ne Yapmal\u0131d\u0131r?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            Kab\u0131zl\u0131k olmamas\u0131 i\u00e7in hasta i\u015flemden sonra bol su i\u00e7meli ve lifli yiyecekler yemelidir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

            \n\t\t\t\t
            \n\t\t\t\t\t

            Prostat\u0131n f\u00fczyon biyopsisini yapman\u0131n tek yolu transrektal y\u00f6ntem midir?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            Uygun hastalarda biyopsi transrektal alan yerine transperineal (testisler ile rektum aras\u0131ndaki b\u00f6lge) yap\u0131labilir. Bu, enfeksiyon risk seviyelerini daha da d\u00fc\u015f\u00fcr\u00fcr. <\/p>

            • <\/i> \u0130htiyac\u0131n rektum duvar\u0131ndan yerle\u015ftirilmesi (transrektal biyopsi). Bu, prostat biyopsisinin en yayg\u0131n y\u00f6ntemidir. <\/li>
            • <\/i> \u0130\u011fnenin rektum ile skrotum transperineal biyopsi aras\u0131ndaki deriden yerle\u015ftirilmesi). Rektum ve skrotum aras\u0131ndaki deride k\u00fc\u00e7\u00fck bir kesi a\u00e7\u0131lacak ve biyopsi i\u011fnesi kesi i\u00e7ine ve prostat\u0131n i\u00e7ine do\u011fru yerle\u015ftirilerek doku \u00f6rne\u011fi al\u0131nacakt\u0131r. MR taramas\u0131 s\u00fcrece rehberlik edecektir. <\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t

              Biyopsinin Olas\u0131 Yan Etkileri Nelerdir?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t\t\t\t\t

              Hemat\u00fcri (idrarda kan) prostat biyopsisinden sonra en s\u0131k g\u00f6r\u00fclen komplikasyondur (%20-63) ve genellikle birka\u00e7 g\u00fcn sonra tamamen ge\u00e7er.<\/p>

              Hematokezya (rektumda kan) da yayg\u0131nd\u0131r ve hastalar\u0131n %2-22’sinde g\u00f6r\u00fcl\u00fcr. Hematospermi (bo\u015falmada kan) klinik olarak \u00f6nemsiz bir sorundur ve i\u015flem sonras\u0131 hastalar\u0131n %50’sinde g\u00f6r\u00fcl\u00fcr ve birka\u00e7 ay devam edebilir. Bula\u015f\u0131c\u0131 komplikasyonlar\u0131n \u00e7o\u011fu antibiyotiklerle kolayca tedavi edilir. Ancak prostat biyopsisi sonras\u0131 \u00f6l\u00fcmc\u00fcl sepsis vakalar\u0131 bildirilmektedir. <\/p>

              \"\"<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

              \n\t\t\t\t\t\t
              \n\t\t\t\t\t
              \n\t\t\t
              \n\t\t\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t

              MR\/TRUS F\u00fczyon Biyopsi Cihazlar\u0131 Tan\u0131t\u0131m Videolar\u0131<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
              \n\t\t\t\t\t\t
              \n\t\t\t\t\t
              \n\t\t\t
              \n\t\t\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t

              URONAV\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t\t\t
              \n\t\t\t
              <\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
              \n\t\t\t
              \n\t\t\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t

              KOEL\u0130S<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t\t\t
              \n\t\t\t
              <\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
              \n\t\t\t\t\t\t
              \n\t\t\t\t\t
              \n\t\t\t
              \n\t\t\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t\t\t
              \n\t\t\t
              <\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
              \n\t\t\t
              \n\t\t\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t\t\t
              \n\t\t\t
              <\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
              \n\t\t\t\t\t\t
              \n\t\t\t\t\t
              \n\t\t\t
              \n\t\t\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t\t\t\t\t

              Sayfam\u0131z bilgilendirme ama\u00e7l\u0131d\u0131r. Tan\u0131 ve Tedavi i\u00e7in doktorunuza ba\u015fvurunuz. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

              Prostat F\u00fczyon Biyopsisi MR\/TRUS F\u00fczyon Biyopsi – Nas\u0131l Yap\u0131l\u0131r? TRUS biyopsisi prostat kanserli hastalarda standart yakla\u015f\u0131m olarak kabul edilir. Ancak prostat kanserinin %25-39’unun izoekoik g\u00f6r\u00fcnmesi, TRUS kullan\u0131larak hedeflenen lezyonlardan \u00f6rnek al\u0131nmas\u0131n\u0131n her zaman m\u00fcmk\u00fcn olmamas\u0131 ve biyopsilerin radikal prostatektomi \u00f6rnekleri ile uyumsuzlu\u011fu, TRUS biyopsisinin do\u011frulu\u011funu art\u0131rmak i\u00e7in ek y\u00f6ntemlere ihtiya\u00e7 oldu\u011funu d\u00fc\u015f\u00fcnd\u00fcrmektedir. Yap\u0131lan \u00e7al\u0131\u015fmalar TRUS […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-6153","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/prostatefocaltherapies.com\/tr\/wp-json\/wp\/v2\/pages\/6153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prostatefocaltherapies.com\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/prostatefocaltherapies.com\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/prostatefocaltherapies.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prostatefocaltherapies.com\/tr\/wp-json\/wp\/v2\/comments?post=6153"}],"version-history":[{"count":1,"href":"https:\/\/prostatefocaltherapies.com\/tr\/wp-json\/wp\/v2\/pages\/6153\/revisions"}],"predecessor-version":[{"id":6177,"href":"https:\/\/prostatefocaltherapies.com\/tr\/wp-json\/wp\/v2\/pages\/6153\/revisions\/6177"}],"wp:attachment":[{"href":"https:\/\/prostatefocaltherapies.com\/tr\/wp-json\/wp\/v2\/media?parent=6153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}